ANI Pharmaceuticals | ANIP - Passività Correnti





Passività Correnti Cambiamento Data
AbbVie USD 42.1B 1.19B 2026-03
ANI Pharmaceuticals USD 239.51M 38.6M 2026-03
Assertio Holdings USD 166.78M 34.25M 2025-09
Aurora Cannabis CAD 145.94M 21.82M 2025-12
Canopy Growth CAD 98.29M 17.19M 2025-12
Eli Lilly USD 36.63B 1.41B 2026-03
Emergent BioSolutions USD 651.3M 12.7M 2023-12
Heron Therapeutics USD 90.52M 5.58M 2026-03
Hikma Pharmaceutical USD 1.45B 603M 2025-12
Knight Therapeutics CAD 165.26M 12.58M 2025-12
Nektar Therapeutics USD 53.54M 12.8M 2025-12
Novartis USD 27.28B 4.72B 2025-12
Omeros USD 85.5M 2.28M 2025-06
Perrigo USD 997.6M 15.3M 2026-03
Sun Pharmaceuticals INR 234.15B 52.21B 2025-09
Teva Pharmaceutical Industries USD 13.53B 76M 2026-03